Peter Clausi
-
Thomas Smeenk provides an update on Hemostemix’s ACP-01 stem cell treatment for heart disease
Peter Clausi interviews Hemostemix Inc.’s (TSXV: HEM | OTCQB: HMTXF) Co-Founder, President and CEO Thomas Smeenk about an…
-
Fission 3.0 Chairman Dev Randhawa discusses high-grade uranium discovery attracting market attention
In this InvestorIntel interview, Peter Clausi interviews Fission 3.0 Corp.‘s (TSXV: FUU | OTCQB: FISOF) CEO and Chairman…
-
InvestorIntel.com Launches Newly Designed Site for Investors in the Capital Markets
November 30, 2022 – Celebrating 21 years in business, InvestorIntel Corp. is pleased to announce that its new website…
-
WCPD’s Peter Nicholson Explains the Win-Win of the Critical Minerals Charitable Flow Through Model
In this InvestorIntel financial education series interview, host Peter Clausi talks to WCPD Inc.’s Founder and President Peter…
-
The IIROC Short Selling Debate
In this InvestorIntel interview, host Tracy Weslosky brings together Power Nickel Inc.‘s (TSXV: PNPN | OTCQB: CMETF) CEO…